Eligibility criteria
The research program follows the PRIMA-P
guidelines[12], and this article is based on the
Preferred Reporting Items for Systematic Reviews and Meta-Analyses
guidelines.[13] The inclusion criteria were as
follows: (1) Population: low-risk surgical patients (Society of Thoracic
Surgeons Predicted Risk of Mortality, STS PROM<4%); (2) Comparison:
TAVI; (3) Control: SAVR; (4) Outcomes: Primary outcomes were all‐cause
mortality and secondary outcomes were cardiovascular mortality, stroke,
transient ischaemic attack (TIA), myocardial infarction (MI), acute
kidney injury (stage 2 or 3), life-threatening or significant bleeding,
permanent pacemaker implantation (PPI), and new atrial fibrillation
(NAF); these outcome measures were assessed over a 2-year
period.[14]; (5) Study design: RCTs.